Francesco Costa
Impact in
- Gastroenterology top 0.5%
- Gastrointestinal motility and disorders
- Immunology top 5%
- Galectins and Cancer Biology
- IL-33, ST2, and ILC Pathways
Papers in
-
- Gastrointestinal motility and disorders 14
- Gastroesophageal reflux and treatments 8
- Genetics 37
- Inflammatory Bowel Disease 32
- Co-authors
- Massimo BelliniSantino MarchiM. ManghettiMario Milco D’EliosCosima T. BaldariGianfranco Del PreteJohn L. TelfordM.G. Mumolo
- Journals
- Gastroenterology (6 papers)Nutrients (6 papers)Digestive and Liver Disease (6 papers)Journal of Clinical Medicine (5 papers)Alimentary Pharmacology & Therapeutics (4 papers)
- Partner nations
- ItalyPortugalUnited States
In The Last Decade
Francesco Costa
112 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 126
- Gastroenterology 690
- Immunology 878
- Genetics 1.0k
- Surgery 1.5k
- Epidemiology 864
Countries citing papers authored by Francesco Costa
This map shows the geographic impact of Francesco Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Costa more than expected).
Fields of papers citing papers by Francesco Costa
This network shows the impact of papers produced by Francesco Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Costa. The network helps show where Francesco Costa may publish in the future.
Co-authors
The 25 scholars most cited alongside Francesco Costa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 27 | |
| 7 | 2020 | 17 | |
| 8 | 2020 | 22 | |
| 9 | 2020 | 25 | |
| 10 | 2019 | 9 | |
| 11 | 2010 | 25 | |
| 12 | 2010 | 23 | |
| 13 | 2009 | 60 | |
| 14 | 2008 | 11 | |
| 15 | 2005 | 39 | |
| 16 | 2003 | 239 | |
| 17 | 2003 | 17 | |
| 18 | 2002 | 14 | |
| 19 | Daily administration of interferon alpha 2b and utility of combination therapy with ribavirin as initial treatment for chronic hepatitis C. | 1999 | 2 |
| 20 | 1998 | 8 |
About Francesco Costa
Francesco Costa is a scholar working on Gastroenterology, Genetics, Epidemiology, Surgery and Issues, ethics and legal aspects, having authored 117 papers that have together received 3.5k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (32 papers), Microscopic Colitis (28 papers), Helicobacter pylori-related gastroenterology studies (26 papers), Gastrointestinal motility and disorders (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Eosinophilic Esophagitis (10 papers), Asthma and respiratory diseases (8 papers) and Gastroesophageal reflux and treatments (8 papers). The work is most often cited by research in Gastroenterology (690 citations), Immunology (878 citations), Genetics (1.0k citations), Surgery (1.5k citations) and Epidemiology (864 citations). Francesco Costa has collaborated with scholars based in Italy, Portugal and United States. Frequent co-authors include Massimo Bellini, Santino Marchi, M. Manghetti, Mario Milco D’Elios, Cosima T. Baldari, Gianfranco Del Prete, John L. Telford, M.G. Mumolo, Nicola de Bortoli and Lorenzo Bertani. Their work appears in journals such as Gastroenterology, Nutrients, Digestive and Liver Disease, Journal of Clinical Medicine and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.